Get a
picture of
Picterus

What started as a research project became Picterus AS in 2015. We bring a transformative approach to neonatal jaundice with our state-of-the-art smartphone application. Our technology is made to be used by anyone who needs it, healthcare providers and caregivers alike.

Under
the lens

Located in Trondheim, by the scenic Norwegian Fjord, Picterus has blossomed into a hub of global talent and innovative ideas. Our commitment extends beyond country borders, striving to elevate the standards of jaundice care worldwide. The strength of our work lies in extensive research, which has resulted in a portfolio of patents and notable certifications, including the CE-certification of our app as a class IIa medical device.

Picterus Jaundice mHealth Platform
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 190162545

We are on a mission
Picterus is dedicated to revolutionizing neonatal jaundice care by offering a universally accessible and accurate screening solution, ensuring a healthy start for every child, anywhere and anytime.

The idea behind Picterus traces back to Dr. Anders Aune’s time in Tanzania in 2012, where he got to experience the widespread devastation of neonatal jaundice first-hand. The lack of a better solution became painfully apparent. Motivated by this realization, he founded Picterus together with Gunnar Vartdal and Lise Lyngsnes Randeberg in 2015. Two years later, our first clinical study was completed. We have been working hard to improve our jaundice screening technology ever since.

In 2023, we received another EIC Accelerator Grant to support the development of our novel digital platform to facilitate neonatal jaundice screening for healthcare professionals and caregivers around the world.